We are using cookies to implement functions like login, shopping cart or language selection for this website. Furthermore we use Google Analytics to create anonymized statistical reports of the usage which creates Cookies too. You will find more information in our privacy policy.
OK, I agree I do not want Google Analytics-Cookies
The International Journal of Oral & Maxillofacial Implants
Login:
username:

password:

Plattform:

Forgotten password?

Registration

Int J Oral Maxillofac Implants 28 (2013), No. 2     15. Mar. 2013
Int J Oral Maxillofac Implants 28 (2013), No. 2  (15.03.2013)

Page 573-578, doi:10.11607/jomi.3088, PubMed:23527362


A Prospective, Open-Ended, Single-Cohort Clinical Trial on Early Loaded Titanium-Zirconia Alloy Implants in Partially Edentulous Patients: Up-to-24-Month Results
Akça, Kivanc / Cavusoglu, Yeliz / Uysal, Serdar / Cehreli, Murat Cavit
Purpose: To evaluate biologic and prosthetic outcomes of titanium-zirconia alloy implants supporting fixed prostheses.
Materials and Methods: A total of 52 titanium-zirconia alloy implants were placed in 23 consecutive patients with partial edentulism. All implants were subjected to an early loading protocol by means of single-unit or up-to-four-unit fixed partial prostheses and observed between 7 and 24 months. The radiographic marginal bone loss and peri-implant soft tissue scores (Plaque Index, Bleeding Index, and Calculus Index) were recorded. In addition, prosthetic complications were recorded during the period of the study.
Results: Early or late implant failures were not observed, resulting in 100% implant survival and success of the implants. No prosthetic complications were observed. The mean (standard deviation) of marginal bone loss for 52 implants was 0.315 mm (0.24 mm). There were no signs of excessive bone loss with or without swelling or suppuration of the peri-implant soft tissue, and the soft tissue scores indicated good soft tissue integration.
Conclusions: Titanium-zirconia alloy implants supporting fixed prostheses showed optimum radiographic, clinical, and prosthetic outcomes in an up-to-24-month assessment period.